» Articles » PMID: 38180840

Syphilis Prevalence Among People Living With and Without HIV in Sub-Saharan Africa: A Systematic Review and Meta-Analysis

Overview
Journal Sex Transm Dis
Date 2024 Jan 5
PMID 38180840
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Syphilis is a curable sexually transmitted infection that, untreated, is associated with significant morbidity and mortality. In people living with HIV (PLWH), syphilis carries greater risks of disease progression. We estimated syphilis prevalence among PLWH in the general population in sub-Saharan Africa and compared the prevalence among PLWH and without HIV.

Methods: We searched for studies published January 1, 2011, to March 28, 2022, reporting syphilis prevalence among PLWH in sub-Saharan Africa (PROSPERO No. CRD42020167328). We excluded studies in high-risk subpopulations. We estimated pooled syphilis prevalence among PLWH using random-effects modeling and compared the prevalence with people without HIV when included in the same study. We examined influences of region, study setting, and test type in subgroup analyses.

Results: We identified 926 studies; 53 were included in the meta-analysis. Pooled syphilis prevalence among PLWH was 7.3% (95% confidence interval [CI], 6.3%-8.5%). Prevalence differed by region: 3.1% (95% CI, 2.2%-4.0%) in Southern, 5.5% (95% CI, 2.3%-9.3%) in West/Central, and 10.5% (95% CI, 8.0%-13.1%) in Eastern Africa. Prevalence also differed by study setting: 13.8% (95% CI, 5.7%-23.0%) in sexual and reproductive health/sexually transmitted infection care, 8.7% (95% CI, 5.0%-12.8%) in HIV care, 7.1% (95% CI, 5.8%-8.5%) in antenatal care, and 3.8% (95% CI, 2.0%-5.8%) in household/community-based settings. Syphilis prevalence was higher among PLWH than without HIV (relative risk, 3.5; 95% CI, 2.8-4.5).

Conclusions: Syphilis is highly prevalent among PLWH in sub-Saharan Africa and is more common among PLWH than without HIV. Integration of syphilis screening and management into HIV care may reduce complications of HIV-syphilis coinfection among PLWH in sub-Saharan Africa.

Citing Articles

Analysis of seroprevalence and risk factors for syphilis and HIV among female sex workers and transgender individuals in different cities of Sindh, Pakistan.

Shah S, Zubair M, Soomro A, Sheikh R, Zhamalbekova A, Abidi S PLoS One. 2025; 20(1):e0312683.

PMID: 39854560 PMC: 11761625. DOI: 10.1371/journal.pone.0312683.


High Incidence of syphilis seroconversion among people living with HIV in Hainan, south China.

Zhu K, Lu C, Yan H, Qiu Y, Qiao F, Zhang W Sci Rep. 2024; 14(1):31432.

PMID: 39733157 PMC: 11682358. DOI: 10.1038/s41598-024-83097-w.


Current syphilis infection in virally suppressed people living with HIV: a cross-sectional study in eastern China.

He L, Pan X, Yang J, Zheng J, Luo M, Cheng W Front Public Health. 2024; 12:1366795.

PMID: 38962784 PMC: 11220119. DOI: 10.3389/fpubh.2024.1366795.

References
1.
Rowley J, Vander Hoorn S, Korenromp E, Low N, Unemo M, Abu-Raddad L . Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019; 97(8):548-562P. PMC: 6653813. DOI: 10.2471/BLT.18.228486. View

2.
Korenromp E, Rowley J, Alonso M, Mello M, Wijesooriya N, Mahiane S . Global burden of maternal and congenital syphilis and associated adverse birth outcomes-Estimates for 2016 and progress since 2012. PLoS One. 2019; 14(2):e0211720. PMC: 6392238. DOI: 10.1371/journal.pone.0211720. View

3.
Rompalo A, Lawlor J, Seaman P, Quinn T, Zenilman J, Hook 3rd E . Modification of syphilitic genital ulcer manifestations by coexistent HIV infection. Sex Transm Dis. 2001; 28(8):448-54. DOI: 10.1097/00007435-200108000-00004. View

4.
Rolfs R, Joesoef M, Hendershot E, Rompalo A, Augenbraun M, Chiu M . A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N Engl J Med. 1997; 337(5):307-14. DOI: 10.1056/NEJM199707313370504. View

5.
Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. PLoS Med. 2021; 18(3):e1003583. PMC: 8007028. DOI: 10.1371/journal.pmed.1003583. View